These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3322582)

  • 21. [Dynamics of anti-insulin antibodies in diabetes mellitus in children (preliminary note)].
    Alexandru E; Popa I; Deutsch G; Murgu L; Bergel E; Lăzărescu-Pavel D; Schmidt Georoceanu A
    Rev Pediatr Obstet Ginecol Pediatr; 1980; 29(1):79-89. PubMed ID: 6770444
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunological aspects of diabetes mellitus in children].
    Popa I; Deutsch G; Oţetea G; Schmidt-Georoceanu A; Man I; Bergel E
    Rev Pediatr Obstet Ginecol Pediatr; 1982; 31(1):63-72. PubMed ID: 6808644
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin antibodies in diabetic children treated with highly purified porcine NPH insulin. Comparison of results obtained by three methods of insulin antibody determination.
    Mäkelä AL; Akerblom HK; Mäkelä P
    Diabete Metab; 1982 Dec; 8(4):341-8. PubMed ID: 7160521
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin--binding antibodies in Nigerian diabetic patients.
    Bella AF; Adetuyibi A
    West Afr J Med; 1990; 9(4):291-4. PubMed ID: 2083207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibodies to insulin in children with diabetes mellitus].
    Enikeev RG
    Vopr Okhr Materin Det; 1975 Feb; 20(2):45-7. PubMed ID: 1136302
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of type 1 diabetes with semisynthetic human insulin. 1 year's experience].
    Lunetta M; Rapisarda S; Leonardi R; Leotta S; Mughini L
    Minerva Endocrinol; 1984; 9(2):125-35. PubMed ID: 6390126
    [No Abstract]   [Full Text] [Related]  

  • 27. [Medium-term results of treatment with biosynthetic human insulin in diabetic children already in therapy with insulin of animal origin].
    Vanelli M; Bolondi O; Boselli E; Chiari G; Vittorangeli R; Rasori E; Nori G; Bernasconi S
    Minerva Pediatr; 1987 Aug; 39(15-16):669-74. PubMed ID: 3312993
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anti-insulin antibodies in children with diabetes mellitus].
    Puskás G; Lukács E; Indig B
    Pediatria (Bucur); 1970; 19(3):221-6. PubMed ID: 5453793
    [No Abstract]   [Full Text] [Related]  

  • 29. The clinical significance of insulin antibodies.
    Andersen OO; Egeberg J
    Acta Paediatr Scand Suppl; 1977; (270):63-8. PubMed ID: 278469
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intensified insulin therapy in children and adolescents with labile diabetes mellitus].
    Lebedev NB; Shcherbacheva LN; Kniazeva AP; Lobanova AM
    Pediatriia; 1989; (11):75-9. PubMed ID: 2691980
    [No Abstract]   [Full Text] [Related]  

  • 31. [Insulin treatment of type I diabetes--a review].
    Arnqvist H
    Lakartidningen; 1986 Jun; 83(25):2311-4. PubMed ID: 3526055
    [No Abstract]   [Full Text] [Related]  

  • 32. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin].
    Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P
    Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of immunological factors in the pathogenesis of insulin dependent diabetes mellitus].
    Pozza G; Cattaneo R; Saibene V; Balestrieri G
    Journ Annu Diabetol Hotel Dieu; 1979; ():221-32. PubMed ID: 502128
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum antibody-bound insulin as a measure of insulin antibodies in diabetic children.
    Koskinen P; Kaihola HL; Mäkelä AL; Irjala K; Knip M; Akerblom HK
    Diabetes Res; 1987 Sep; 6(1):15-9. PubMed ID: 3319351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deleterious effect of anti-insulin antibodies on diabetes control.
    Livneh A; Avraham H; Bistritzer T; Weisglass L; Theodor R; Sack J
    Isr J Med Sci; 1990 Jan; 26(1):11-5. PubMed ID: 2179155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous insulin resistance syndrome. Effects of long-term aprotinin therapy.
    Guillausseau PJ; Guillausseau C; Boucheteil P; Lubetzki J
    Diabetes Res; 1986 Sep; 3(7):387-9. PubMed ID: 2430751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of semisynthetic human insulin in juvenile insulin-dependent diabetes mellitus].
    Sacchetti C; Foco A; David O; Balboni R; Gargano P; Cerutti F; Baratono S
    Minerva Pediatr; 1989 May; 41(5):221-2. PubMed ID: 2677642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin autoantibodies and insulin-induced antibodies in children with insulin-dependent diabetes].
    Bridel MP; Tubiana-Rufi N; Levy-Marchal C
    Diabete Metab; 1992; 18(6):459-62. PubMed ID: 1297603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insulin antibodies in diabetes in children at the age of puberty].
    Walczak M; Michalkiewicz M; Piontek E; Paluszak W
    Pediatr Pol; 1975 Sep; 50(9):1113-8. PubMed ID: 1165940
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of type I diabetes mellitus with biosynthetic human insulin].
    Guagnano MT; Anichini M; Della Loggia F; Renzetti A; Vitacolonna E; Sensi S
    Boll Soc Ital Biol Sper; 1985 Sep; 61(9):1267-72. PubMed ID: 3907668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.